Elina Buitrago
Papers
1
Total Citations
31
H-Index
1
About
Dr. Elina Buitrago is a distinguished researcher in the field of asymmetric catalysis and synthetic methodology, with a particular focus on the development of sustainable and efficient routes to pharmaceutically relevant compounds. Her major contributions center on the design and high-throughput screening of novel catalyst libraries, notably for the asymmetric transfer hydrogenation of heteroaromatic ketones. A landmark study from 2012, which has garnered 31 citations, exemplifies her innovative approach: by systematically screening a library of 21 amino acid-based ligands (including hydroxy amide, thioamide, and hydroxamic acid functionalities) paired with ruthenium and rhodium precursors, she achieved highly enantioselective reductions. This work was not merely methodological; it enabled the formal syntheses of two important antidepressant drugs, (R)-Fluoxetine and (S)-Duloxetine, demonstrating the direct translational impact of her research. Dr. Buitrago’s work is notable for bridging the gap between combinatorial catalyst discovery and practical, asymmetric synthesis, providing a powerful toolkit for the preparation of chiral building blocks. Her achievements underscore a career dedicated to advancing the efficiency and selectivity of catalytic processes, making her a key figure in modern synthetic organic chemistry.
Research Focus
Key Achievements
Top Papers
- 1